Arcturus Therapeutics Holdings Inc.

ARCT

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001768224

SEC filings (opens in a new tab)

No open-market purchases or sales by Arcturus Therapeutics Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; ARK Invest is the only superinvestor holding it.

Q2 2023 vs. Q1 2023

How the institutions holding Arcturus Therapeutics Holdings Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of ARCT: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Of which not filed for Q2 2023	Q2 2023	Change
Holders	124	1	144	+21
Shares	23.3M	8.89K	23.6M	+321.9K (+1.4%)
Value	$557.9M	$213.1K	$677.6M	+$119.9M (+21.5%)

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to ARCT in Q2 2023
Institution	Shares	Value	% of portfolio
Renaissance Technologies LLC	265,700	$7.62M	0.01%
Arrowstreet Capital, Limited Partnership	127,244	$3.65M	0.00%
D. E. Shaw & Co., Inc.	102,087	$2.93M	0.00%
Marshall Wace, LLP	84,371	$2.42M	0.01%
Qube Research & Technologies Ltd	83,313	$2.39M	0.01%
Putnam Investments LLC	65,037	$1.87M	0.00%
AQR Capital Management LLC	50,676	$1.45M	0.00%
Connor, Clark & Lunn Investment Management Ltd.	43,634	$1.25M	0.01%
Voloridge Investment Management, LLC	42,007	$1.20M	0.01%
Massachusetts Financial Services Co	39,207	$1.12M	0.00%
DekaBank Deutsche Girozentrale	40,000	$1.06M	0.00%
Trexquant Investment LP	34,641	$993.5K	0.03%
Victory Capital Management Inc	24,680	$707.8K	0.00%
STRS Ohio	23,900	$685.0K	0.00%
Houlihan Financial Resource Group, Ltd.	21,700	$591.0K	0.02%
Alps Advisors Inc	19,524	$559.9K	0.00%
Franklin Resources Inc	19,063	$546.7K	0.00%
Globeflex Capital L P	18,047	$517.6K	0.06%
Jacobs Levy Equity Management, Inc	17,238	$494.4K	0.00%
Cambria Investment Management, L.P.	17,155	$492.0K	0.04%
Ziegler Capital Management, LLC	16,800	$481.8K	0.02%
American Century Companies Inc	13,693	$392.7K	0.00%
Gotham Asset Management, LLC	12,029	$345.0K	0.01%
Virginia Retirement Systems Et Al	11,200	$321.2K	0.00%
Alberta Investment Management Corp	9,602	$275.4K	0.00%
Winton Group Ltd	9,507	$272.7K	0.02%
Headlands Technologies LLC	2,095	$60.1K	0.02%
Amundi	1,661	$47.6K	0.00%
CWM, LLC	365	$10.0K	0.00%
Northwestern Mutual Wealth Management Co	50	$1.43K	0.00%
Federation des caisses Desjardins du Quebec	10	$287	0.00%
Sofos Investments, Inc.	29	$66	0.00%

Sold out (11)

Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of ARCT in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Prosight Management, LP	255,000	$6.11M
Balyasny Asset Management LLC	107,653	$2.58M
Gsa Capital Partners LLP	28,827	$691.0K
Candriam Luxembourg S.C.A.	29,401	$648.7K
Natixis	11,500	$275.7K
Jefferies Financial Group Inc.	10,200	$244.5K
SG Americas Securities, LLC	10,086	$242.0K
Bayesian Capital Management, LP	9,499	$227.7K
State Board of Administration of Florida Retirement System	8,841	$211.9K
Russell Investments Group, Ltd.	4,300	$103.1K
Itau Unibanco Holding S.A.	1,111	$26.6K

Not filed for Q2 2023 yet (1)

Institutions that held Arcturus Therapeutics Holdings Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ARCT in Q1 2023 that haven't filed for Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
ETF Managers Group, LLC	8,890	$213.1K